跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Itorvaz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Itorvaz
Approved
STANDARD
Itorvaz
The Acme Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bf554957bb966024
Company
The Acme Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
bf554957bb966024
Drug Approval Philippines Name
Itorvaz
Product Name
Itorvaz
Registration Number
DRP-6081
Brand Name
Itorvaz
Generic Name
Atorvastatin (as calcium)
Dosage Form
Film Coated Tablet
Dosage Strength
40mg
Manufacturer
The Acme Laboratories Ltd.
Importer
Euro Generics International Phils., Inc.
Distributor
Bell-Kenz Pharma Inc.
Company Detail Path
/organization/the-acme-laboratories-ltd
Issuance Date
28 February 2022
Expiry Date
18 May 2027
Pharmacologic Category
HMG-CoA Reductase Inhibitors
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bf554957bb966024
Type
Standard
Back to Philippines FDA Approvals